Nasdaq: ARQT
Arcutis Biotherapeutics insiders
The officers, directors and 10% owners of Arcutis Biotherapeutics, Inc. who hold the most stock, valued at the live ARQT price.
$27.17
ARQT today −$440K (−1.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 9
- Their ARQT stock
- $546M
- Market value
- $3.44B
- Held by ranked insiders
- 15.9%
Insiders by value of ARQT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences VIII, L.P. | 10% owner | 8,827,254 | $240M | 6.98% | Corporate |
| 2 | Fhm Life Sciences Viii, L.P. | 10% owner | 8,738,567 | $237M | 6.91% | Corporate |
| 3 | Bhaskar Chaudhuri | Director | 917,807 | $24.9M | 0.73% | 4263rd |
| 4 | Todd Watanabe | See Remarks | 776,318 | $21.1M | 0.61% | 4983rd |
| 5 | David W. Osborne | Chief Technical Officer | 268,854 | $7.3M | 0.21% | 11069th |
| 6 | Christopher Peetz | Director | 191,815 | $5.2M | 0.15% | 2840th |
| 7 | Larry Todd Edwards | See Remarks | 175,178 | $4.8M | 0.14% | 6613th |
| 8 | John W. Smither | Chief Financial Officer | 152,757 | $4.2M | 0.12% | 12738th |
| 9 | Scott L. Burrows | Chief Financial Officer | 59,115 | $1.6M | <0.1% | 9209th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arcutis Biotherapeutics; see each profile for the filing.